 MENLO PARK, Calif. and BOSTON, April 13, 2021 GLOBE NEWSWIRE -- Adicet Bio, Inc. Nasdaq: ACET, a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the appointment of Blake Aftab, Ph.D., as Vice President of Research. Dr. Aftab will lead Adicets research group and will further develop existing and new opportunities for the Companys gamma delta T cell platform. 